close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about KALV

Recent news which mentions KALV

< Previous 1 2 Next >
KalVista Pharmaceuticals: Q3 Earnings Insights
Tickers KALV
Tags Benzinga Earnings Market News
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Tickers ACAD ACLX AMRN AMRS
Tags CTIC FGEN AMRX
From Benzinga
KalVista Pharmaceuticals: Q2 Earnings Insights
Tickers KALV
Tags Market News KALV BZI/Recaps
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Tickers ACIU ADMA AFMD AMPE
Tags CERE FDA BTAI
From Benzinga
Why KalVista Pharmaceuticals' Stock Is Trading Higher Today
Tickers KALV
Tags Benzinga BZI/WIIM Trading Ideas
From Benzinga
FDA Lifts Clinical Hold On KalVista's Hereditary Angioedema Trial
Tickers KALV
Tags News General Briefs
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Tickers ABSI ABT AZN BIVI
Tags SYK AZN ESPR
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers APM ARPO ATNF CLDX
Tags NVOS Top Gainers Movers
From Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Tickers ALEC AMAM ANGO ATAI
Tags MOLN BIIB AVEO
From Benzinga
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Tickers ACER AERI AMPH BCRX
Tags Previews ZYNE Needham
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today